纳米药物载体介导的联合给药逆转肿瘤多药耐药的研究进展(5)
[19] LV L，LIU CX，CHEN CX，et al. Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer[J]. Oncotarget，2016，7(22)：32184-32199.
[20] LIU Q，LI J，PU GB，et al. Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy[J]. Drug Deliv，2016，23(4)：1364-1368.
[21] ZOU WT，SARISOZEN C，TORCHILIN VP. The reversal of multidrug resistance in ovarian carcinoma cells by co-application of tariquidar and paclitaxel in transferrin-targeted polymeric micelles[J]. J Drug Target，2017，25(3)：225-234.
, http://www.100md.com
[22] WANG W，XI M，DUAN XZ，et al. Delivery of baicalein and paclitaxel using self-assembled nanoparticles：synergistic antitumor effect in vitro and in vivo[J]. Int J Nanomed，2015.DOI：10.2147/IJN.S80297.
[23] BUTT AM，MOHD AMIN MC，KATAS H. Synergistic effect of pH-responsive folate-functionalized poloxamer 407-TPGS-mixed micelles on targeted delivery of anticancer drugs[J]. Int J Nanomed，2015.DOI：10.2147/IJN.S78438.
[24] ASSANHOU AG，LI W，ZHANG L，et al. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment[J]. Biomaterials，2015.DOI：10.1016/j.biomaterials.2015.09.022.
, 百拇医药
[25] 任章霞，李凡，楊蕙嘉，等.替吉奥联合多西他赛治疗蒽环类药物耐药的复发转移性乳腺癌的临床观察[J].中国药房，2013，24(48)：4571-4573.
[26] 韩淑燕，郑文献，何曦冉，等.消癌平注射液联合吉非替尼对耐药非小细胞肺癌H460和H1975裸鼠移植瘤的抑制作用[J].中国药理学与毒理学杂志，2016，30(1)：44-52.
[27] CHEN YZ，ZHANG W，HUANG YK，et al. Pluronic- based fuctional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor[J]. Int J Pharm，2015，488(1/2)：44-58.
[28] PRASAD P，SHUHENDLER A，CAI P，et al. Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts[J]. Cancer Lett，2013，334((2)：263-273.
, http://www.100md.com
[29] GONG MQ，WU C，HE XY，et al. Tumor targeting synergistic drug delivery by self-assembled hybrid nanovesicles to overcome drug resistance[J]. Pharm Res，2017，34(1)：148-160.
[30] SIVAK L，SUBR V，TOMALA J，et al. Overcoming multidrug resistance via simultaneous delivery of cytostatic drug and P-glycoprotein inhibitor to cancer cells by HPMA copolymer conjugate[J]. Biomaterials，2017.DOI：10.1016/j.biomaterials.2016.11.013.
[31] ZHAO L，YANG G，SHI YJ，et al. Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance[J]. J Nanobiotech，2015，13(1)：57-66., 百拇医药(曹晓孚 孟路华 刘振 冯蕾 赵艳艳 李兰芳 闫春章)
[20] LIU Q，LI J，PU GB，et al. Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy[J]. Drug Deliv，2016，23(4)：1364-1368.
[21] ZOU WT，SARISOZEN C，TORCHILIN VP. The reversal of multidrug resistance in ovarian carcinoma cells by co-application of tariquidar and paclitaxel in transferrin-targeted polymeric micelles[J]. J Drug Target，2017，25(3)：225-234.
, http://www.100md.com
[22] WANG W，XI M，DUAN XZ，et al. Delivery of baicalein and paclitaxel using self-assembled nanoparticles：synergistic antitumor effect in vitro and in vivo[J]. Int J Nanomed，2015.DOI：10.2147/IJN.S80297.
[23] BUTT AM，MOHD AMIN MC，KATAS H. Synergistic effect of pH-responsive folate-functionalized poloxamer 407-TPGS-mixed micelles on targeted delivery of anticancer drugs[J]. Int J Nanomed，2015.DOI：10.2147/IJN.S78438.
[24] ASSANHOU AG，LI W，ZHANG L，et al. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment[J]. Biomaterials，2015.DOI：10.1016/j.biomaterials.2015.09.022.
, 百拇医药
[25] 任章霞，李凡，楊蕙嘉，等.替吉奥联合多西他赛治疗蒽环类药物耐药的复发转移性乳腺癌的临床观察[J].中国药房，2013，24(48)：4571-4573.
[26] 韩淑燕，郑文献，何曦冉，等.消癌平注射液联合吉非替尼对耐药非小细胞肺癌H460和H1975裸鼠移植瘤的抑制作用[J].中国药理学与毒理学杂志，2016，30(1)：44-52.
[27] CHEN YZ，ZHANG W，HUANG YK，et al. Pluronic- based fuctional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor[J]. Int J Pharm，2015，488(1/2)：44-58.
[28] PRASAD P，SHUHENDLER A，CAI P，et al. Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts[J]. Cancer Lett，2013，334((2)：263-273.
, http://www.100md.com
[29] GONG MQ，WU C，HE XY，et al. Tumor targeting synergistic drug delivery by self-assembled hybrid nanovesicles to overcome drug resistance[J]. Pharm Res，2017，34(1)：148-160.
[30] SIVAK L，SUBR V，TOMALA J，et al. Overcoming multidrug resistance via simultaneous delivery of cytostatic drug and P-glycoprotein inhibitor to cancer cells by HPMA copolymer conjugate[J]. Biomaterials，2017.DOI：10.1016/j.biomaterials.2016.11.013.
[31] ZHAO L，YANG G，SHI YJ，et al. Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance[J]. J Nanobiotech，2015，13(1)：57-66., 百拇医药(曹晓孚 孟路华 刘振 冯蕾 赵艳艳 李兰芳 闫春章)